“Glucagon-Like-Peptide 1 (GLP-1) Receptor Agonists in Rheumatologic Disease”. Canadian Rheumatology Today, vol. 2, no. 1, June 2025, pp. 17–23, https://doi.org/10.58931/crt.2025.2158.